EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Expression and role of the long noncoding RNA Linc00909 in chemoradiotherapy for colorectal cancer

Yong Wu, Yi-Yi Zhang, Bing-Jie Guan, Hua-Jun Cai, Guo-Xian Guan

World Journal of Gastrointestinal Surgery · 2026-11-27 · 18 (11)

DOI: 10.4240/wjgs.121769 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Colorectal cancer is one of the major malignant tumors worldwide. Previous studies have shown that long noncoding RNAs have significant effects on various human cancers, but the underlying molecular mechanisms remain unclear. AIM To investigate the impact of the long noncoding RNA Linc00909 on colorectal cancer and its molecular mechanism. METHODS Using 196 paired colorectal cancer and adjacent tissues from 30 patients with rectal cancer (19 resistant, 11 sensitive) to neoadjuvant chemoradiotherapy, we assessed Linc00909 expression using real-time quantitative polymerase chain reaction and correlated it with survival outcomes. Functional assays in Linc00909-overexpressing SW620 and DLD1 cells—including Cell Counting Kit-8 assays, flow cytometry, and sphere formation—evaluated proliferation, cell cycle, apoptosis, stemness, and 5-fluorouracil/radiotherapy sensitivity. Tumorigenicity was examined in vivo . Bioinformatic and molecular experiments explored Linc00909’s competing endogenous RNA mechanism. RESULTS Linc00909 was upregulated in resistant and tumor tissues and independently predicted poorer overall and disease-free survival. Linc00909 overexpression enhanced proliferation, colony formation, antiapoptotic capacity, stemness, and therapy resistance in vitro and promoted tumor growth in vivo . miR-625-5p was bioinformatically predicted and experimentally validated as a binding target of Linc00909, with its expression decreasing upon Linc00909 overexpression. SOX2 was identified as a downstream target of miR-625-5p and showed increased expression at both the messenger RNA and protein levels following Linc00909 upregulation. CONCLUSION Linc00909 can affect the proliferation, colony formation, apoptosis, cell cycle regulation, spheroid-forming ability, and sensitivity of colorectal cancer cells to 5-fluorouracil and radiotherapy. Mechanistically, Linc00909 may regulate the expression of the downstream target gene SOX2 by sequestering miR-625-5p, thereby influencing the sensitivity of colorectal cancer cells to radiotherapy and chemotherapy. Therefore, Linc00909 can be considered a potential therapeutic target for treating colorectal cancer.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →